During the last session, ENDRA Life Sciences Inc (NASDAQ:NDRA)’s traded shares were 1.96 million, with the beta value of the company hitting 0.78. At the end of the trading day, the stock’s price was $0.25, reflecting an intraday loss of -11.00% or -$0.03. The 52-week high for the NDRA share is $139.50, that puts it down -55700.0 from that peak though still a striking 28.0% gain since the share price plummeted to a 52-week low of $0.18. The company’s market capitalization is $4.57M, and the average intraday trading volume over the past 10 days was 42.84 million shares, and the average trade volume was 10.19 million shares over the past three months.
ENDRA Life Sciences Inc (NDRA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. NDRA has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -1.78.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information
ENDRA Life Sciences Inc (NDRA) registered a -11.00% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -11.00% in intraday trading to $0.25, hitting a weekly high. The stock’s 5-day price performance is -16.69%, and it has moved by 24.94% in 30 days. Based on these gigs, the overall price performance for the year is -99.49%. The short interest in ENDRA Life Sciences Inc (NASDAQ:NDRA) is 0.72 million shares and it means that shorts have 0.51 day(s) to cover.
ENDRA Life Sciences Inc (NDRA) estimates and forecasts
Statistics show that ENDRA Life Sciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. ENDRA Life Sciences Inc (NDRA) shares have gone down -98.48% during the last six months, with a year-to-date growth rate more than the industry average at 85.97% against 14.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 91.10% this quarter and then jump 28.80% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 48.47%. While earnings are projected to return 85.97% in 2024.
NDRA Dividends
ENDRA Life Sciences Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders
ENDRA Life Sciences Inc insiders own 0.28% of total outstanding shares while institutional holders control 0.09%, with the float percentage being 0.09%.
